EMAIL THIS PAGE TO A FRIEND

Patologicheskaia fiziologiia i eksperimental'naia terapiia

[The prevention of the development of the collagen-induced microembolic syndrome by decreasing the hydrodynamic resistance of the blood with special polymers under flow].


PMID 1798660

Abstract

The search for antiaggregatory compounds is undertaken, as a rule, under in vitro conditions which do not reflect the dynamics of the real process. The present work deals with study of the peculiarities of the development of the collagen induced microembolic syndrome and the effect produced on it by hydrodynamic resistance reducing polymers under conditions modelling real circulation. The authors show the formation of a developed microembolic syndrome under the effect of collagen with accumulation of vasoconstrictors in the environment and increase of red cell hemolysis. Reduction of blood flow turbulence by the addition of solutions of neutral high-molecular linear polymers revealed the inhibiting effect of these polymers on the development of intracellular aggregate formation and concomitant red cell microhemolysis, which was attended by sharp reduction of thromboxane A2 production in the experiment. The authors show the significance of hemodynamic conditions in the development of the microembolic syndrome and the possibility of preventing it under conditions of modification of the blood flow with polymers, which may be of high prophylactic importance.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

91462
Kollisolv® PEG E 300
06855
Kollisolv® PEG E 400
P3015
Poly(ethylene glycol), average mol wt 200
88440
Poly(ethylene glycol), BioUltra, 200
81162
Poly(ethylene glycol), tested according to Ph Eur, 300
202371
Poly(ethylene glycol), average Mn 300
90878
Poly(ethylene glycol), BioUltra, 300
91893
Poly(ethylene glycol), BioUltra, 400
202398
Poly(ethylene glycol), average Mn 400
81172
Poly(ethylene glycol), tested according to Ph Eur, 400
P3265
Poly(ethylene glycol), average mol wt 400
202401
Poly(ethylene glycol), average Mn 600, waxy solid (moist)
87333
Poly(ethylene glycol), BioUltra, 600
P3515
Poly(ethylene glycol), average Mn 950-1,050
81188
Poly(ethylene glycol), BioUltra, 1,000
81189
Poly(ethylene glycol), BioUltra, for molecular biology, 1,000
03395
Poly(ethylene glycol), tested according to Ph Eur, 1,000
202436
Poly(ethylene glycol), average Mn 1,305-1,595, waxy solid
P5402
Poly(ethylene glycol), average mol wt 1,450
81210
Poly(ethylene glycol), average Mw 1,500
86101
Poly(ethylene glycol), BioUltra, 1,500
84797
Poly(ethylene glycol), BioUltra, 2,000
81227
Poly(ethylene glycol), BioUltra, 3,000
295906
Poly(ethylene glycol), average Mn 2,050, chips
P2906
Poly(ethylene glycol), Hybri-Max, mol wt 3,000-3,700, waxy solid, BioReagent, suitable for hybridoma
202444
Poly(ethylene glycol), average Mn 3,350, powder
P3640
Poly(ethylene glycol), average mol wt 3015-3685
88276
Poly(ethylene glycol), BioUltra, 3,350
P4338
Poly(ethylene glycol), BioXtra, average mol wt 3,350, powder
95904
Poly(ethylene glycol), BioUltra, 4,000